The fast pace of information can make it difficult to efficiently apply data to care.
Clinical Forum
Pharmacists can improve both quality of life and financial toxicity for patients.
Pharmacists also have the resources to help advocate for better care for patients.
A plethora of targeted therapies, biomarker-driven therapies, and immunotherapies are now available.
High-risk areas for disease progression include genitalia and the scalp.
An expert shares information on risk factors and controversies around testing.
Pharmacologic approaches can reduce the risk of chronic GVHD.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
Gedatolisib Triplet Shows Significant PFS Benefit in HR+/HER2– Breast Cancer
4
Less Common Pneumococcal Serotypes Cause More Severe Community-Acquired Pneumonia
5
